Dozens of Swedish doctors, scientists criticize country's coronavirus approach in grim op-ed
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
Sweden's unique approach to the coronavirus pandemic has drawn a lot of scrutiny from the rest of the world after the country chose to forego the harsh lockdowns enacted by many of its European peers. But now several of the country's own doctors and scientists are speaking out against the strategy in an op-ed published Tuesday by USA Today.
The experts warned other nations not to follow the Nordic country's footsteps. "At the moment, we have set an example for the rest of the world on how not to deal with a deadly infectious disease," the piece reads.
The evidence seems to back up the signees' grim outlook — Sweden has a per capita death toll greater than the United States, as well as a raw death toll that is 4.5 times greater than the other four Nordic countries (Iceland, Denmark, Finland, and Norway) combined, the op-ed notes. And the country's fatality rate has also been gaining on Italy, the first European country to be hit hard by COVID-19.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The signees expressed optimism about new medical treatments and vaccines, but until then, they said, don't do things "the Swedish way."
The same day as the op-ed, a report from the research firm Capital Economics suggested Sweden did weather the economic storm brought on by the virus better than its European counterparts and said the forecasted 1.5 percent drop in GDP this year "is well above consensus." However, the report also noted that Sweden was simply "the best of a bad bunch." Read the full op-ed at USA Today, as well as more about Sweden's economic situation at Business Insider.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Buddhist monks’ US walk for peaceUnder the Radar Crowds have turned out on the roads from California to Washington and ‘millions are finding hope in their journey’
-
American universities are losing ground to their foreign counterpartsThe Explainer While Harvard is still near the top, other colleges have slipped
-
How to navigate dating apps to find ‘the one’The Week Recommends Put an end to endless swiping and make real romantic connections
-
A Nipah virus outbreak in India has brought back Covid-era surveillanceUnder the radar The disease can spread through animals and humans
-
Trump HHS slashes advised child vaccinationsSpeed Read In a widely condemned move, the CDC will now recommend that children get vaccinated against 11 communicable diseases, not 17
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
